Topic: geneediting

Adeno-Associated Virus Vector Manufacturing Market Expected to Reach $3.21 Billion by 2030, Driven by Gene Therapy Advancements The global adeno-associated virus (AAV) vector manufacturing market is projected to reach USD 3.21 billion by 2030, growing at a compound annual growth rate (CAGR) of approximately 12.8%, according to a new report by Maximize Market Research. This growth is fueled by the increasing adoption of gene therapies, particularly in gene augmentation and immunotherapy applic...